These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7276093)
1. Inhibition of leukocyte locomotion by hyaluronic acid. Forrester JV; Wilkinson PC J Cell Sci; 1981 Apr; 48():315-31. PubMed ID: 7276093 [TBL] [Abstract][Full Text] [Related]
2. Effect of hyaluronic acid on neutrophil adhesion. Forrester JV; Lackie JM J Cell Sci; 1981 Aug; 50():329-44. PubMed ID: 7320071 [TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Matzner Y; Marx G; Drexler R; Eldor A Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320 [TBL] [Abstract][Full Text] [Related]
4. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide. Marasco WA; Becker EL; Oliver JM Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408 [TBL] [Abstract][Full Text] [Related]
5. Effects of ascorbic acid on neutrophil locomotion. Dallegri F; Lanzi G; Patrone F Int Arch Allergy Appl Immunol; 1980; 61(1):40-5. PubMed ID: 7350124 [TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones. Harvath L; Yancey KB; Katz SI J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine. Harvath L; McCall CE; Bass DA; McPhail LC J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802 [TBL] [Abstract][Full Text] [Related]
13. Crawling-like movements, adhesion to solid substrata and chemokinesis of neutrophil granulocytes. Keller HU; Zimmermann A; Cottier H J Cell Sci; 1983 Nov; 64():89-106. PubMed ID: 6662865 [TBL] [Abstract][Full Text] [Related]
14. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. Seligmann BE; Fletcher MP; Gallin JI J Immunol; 1983 Apr; 130(4):1902-9. PubMed ID: 6131922 [TBL] [Abstract][Full Text] [Related]
15. The influence of high molecular weight sodium hyaluronate (Healon) on the production of migration inhibitory factor. van der Gaag R; Broersma L; Koornneef L Curr Eye Res; 1987 Dec; 6(12):1433-40. PubMed ID: 3322686 [TBL] [Abstract][Full Text] [Related]
16. Impaired neutrophil locomotion associated with hyperadhesiveness in a patient with Chédiak-Higashi syndrome. Keller HU; Morell A; Schaffner T; Zimmermann A; Schaad U Blood Cells; 1984; 10(1):37-43. PubMed ID: 6487813 [TBL] [Abstract][Full Text] [Related]
17. In vitro effects of synthetic chemotactic peptides on neutrophil function. Patrone F; Dallegri F; Bonvini E; Sacchetti C Int Arch Allergy Appl Immunol; 1980; 62(3):316-23. PubMed ID: 7390636 [TBL] [Abstract][Full Text] [Related]
18. Comparison of locomotion, chemotaxis and adhesiveness of rabbit neutrophils from blood and peritoneal exudates. Keller HU; Cottier H Blood Cells; 1984; 10(1):45-57. PubMed ID: 6487814 [TBL] [Abstract][Full Text] [Related]
19. Human neutrophil chemokinesis and polarization induced by hyaluronic acid derivatives. Campoccia D; Hunt JA; Doherty PJ; Zhong SP; Callegaro L; Benedetti L; Williams DF Biomaterials; 1993 Dec; 14(15):1135-9. PubMed ID: 8130317 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel chemotactic factor for neutrophils in the bronchial secretions of patients with cystic fibrosis. Dudez TS; Chanson M; Schlegel-Haueter SE; Suter S J Infect Dis; 2002 Sep; 186(6):774-81. PubMed ID: 12198611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]